We’re investing in the future of human vitality.
An operator‑led investment platform for founders and allocators advancing healthtech, medtech, biotech, ambient AI, and resilience infrastructure.
We back companies and systems driving humanity forward, accelerating human health, intelligence, and resilience worldwide.
Breakthroughs stall without the right partner.
Elphina provides capital and embedded operators to help founders navigate regulated markets, prove value, and scale globally—while giving investors disciplined governance and financial attribution.
This information describes our approach and is not an offer or solicitation. See Legal & Compliance.
Industry-wide, most early investments stall at pilot or proof‑of‑concept. We expect more, and we roll up our sleeves to get it.
We accelerate sustained, global growth for the innovators of our future without sacrificing rigorous governance or return discipline for the investors behind them.
We’re more than a fund. We’re capital that sits beside you.
“The Next Frontier in Tech Isn’t Just Smart… It’s Personal, Accessible, And Deeply Impactful to Humans Where They Live, Work, And Play”.
— Dr Christine Perales, CEO GP Elphina Humanity Centric Fund
We don’t hand you an excel spreadsheet with discount codes and say good luck.
We embed experienced operators for 90–180 days to help founders in regulated markets move from pilots to paying partnerships—with compliance and go‑to‑market readiness built in.
Operator sprints (product, GTM, regulatory)
HIPAA/FDA/IRB, GDPR, and enterprise security
Distribution access via employers, health systems, and partners
Describes our approach; not an offer or guarantee of results. See Legal & Compliance.
Our Community
-
Typical initial check $500k–$3M • lead or co‑lead • embedded operator sprint (90–180 days)
Capital + operator expertise for complex, regulated markets
Accelerate adoption in healthtech, medtech, biotech, and AI
Global expansion and compliance fluency
-
Access diversified growth across biotech, AI, and longevity science
Governance and reporting that meet institutional standards
Transparent impact metrics aligned to human progress
Quarterly NAV • semi‑annual LP calls • annual audit • IRIS+/GRI‑aligned impact reporting
-
Join our embedded sprint network
Deploy expertise in compliance, GTM, and innovation strategy
Shape the infrastructure of modern vitality
Join structured sprints with defined KPIs; options for advisory retainers or equity participation
Say hello to VitalTechAI™, our thesis for the future of human vitality.
VitalTechAI™ defines the systems we fund: intelligent, bio-adaptive technologies that connect health, cognition, and environment. These are the innovations that make progress measurable in human terms — from ambient AI that supports neuro-wellness to biotech and regenerative infrastructure that extend health span and resilience.
We invest where innovation serves people, not where it displaces them.
We believe impact isn’t a trend; it’s the infrastructure of the next economy.
Our thesis funds technologies and infrastructure that make progress personal, accessible, and deeply effective in the places life actually happens.
Our Approach
Source & Diligence
Frontier ventures in healthtech, medtech, biotech, ambient AI, & wellness infrastructure.
Embed & Execute
90-180 embedded support sprints to convert clinical pilots, enterprise proofs, and R&D milestones into paying partnerships.
Scale & Measure
Global expansion, secure distribution, and deliver transparent, audited impact.
Generate strong returns and be the catalyst for the systems that sustain civilization.
Elphina delivers impact and performance — combining operator execution, governance rigor, and global scale across ventures advancing human health, intelligence, and resilience.
We manage capital with precision, transparency, and conviction. Every investment is ESG-aligned, SDG-compliant, and audited against end-to-end attribution — from quality-adjusted life years (QALYs) gained to economic value creation in underserved markets.
Quarterly NAV + semi‑annual LP calls
Annual audit
IRIS+/GRI‑aligned impact reporting
Cross‑sector pipeline access